Jefferies analyst Glen Santangelo raised the firm’s price target on Hims & Hers to $25 from $21 and keeps a Hold rating on the shares. A ...

(Hims & Hers Health) Telehealth provider Hims & Hers Health is defending its Super Bowl ad, which is styled as a political manifesto against weight-loss treatments priced “for profits ...

GMA” caught up with the newly-crowned Super Bowl MVP at Walt Disney World after the Philadelphia Eagles’ big win against the Kansas City Chiefs. The tele-health company Hims & Hers Health is ...

But the many millions of people who tune into the Super Bowl won't learn that from this ad." For its part, Hims & Hers maintains that the 'Sick of the System' ad – its first for a Super Bowl ...

Why not? Well, BofA didn't say exactly, but as I argued yesterday, February's spike in sales owed primarily to heavy ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Last month, HIMS saw a spike in sales from the Super Bowl event, but investors started to cast doubt that it would sustain momentum due to the FDA’s exclusion of the Wegovy and Ozempic from the ...

In its latest report, Bank of America assigned an “underperform” rating on HIMS stock as a spike in advertising spending on the Super Bowl event last month would not seem to prop up sales for ...

A Costly Bet That Might Not Pay Off Hims went all-in on weight loss. It spent an estimated $16 million on a Super Bowl ad in February. Its total marketing costs ballooned to $678.8 million in 2024 ...

Weight loss platform Noom launched a full-page print ad in The Wall Street Journal this week, calling on policymakers to create new guidance around expensive drugs, as compounded GLP-1s are set to be ...